Emma Nye

ORCID: 0000-0001-9154-3526
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Melanoma and MAPK Pathways
  • Cancer Immunotherapy and Biomarkers
  • RNA modifications and cancer
  • Cutaneous Melanoma Detection and Management
  • Digestive system and related health
  • Immune responses and vaccinations
  • Lung Cancer Treatments and Mutations
  • Cancer Cells and Metastasis
  • Cancer, Hypoxia, and Metabolism
  • Peptidase Inhibition and Analysis
  • Genetic factors in colorectal cancer
  • Epigenetics and DNA Methylation
  • Computational Drug Discovery Methods
  • Immune Cell Function and Interaction
  • Cancer-related Molecular Pathways
  • Diet and metabolism studies
  • Neuroendocrine Tumor Research Advances
  • Ubiquitin and proteasome pathways
  • Lung Cancer Research Studies
  • Genetics and Neurodevelopmental Disorders
  • Wnt/β-catenin signaling in development and cancer

The Francis Crick Institute
2016-2025

Cancer Research UK
2007-2023

CRUK Lung Cancer Centre of Excellence
2023

Royal United Hospital Bath NHS Trust
2023

Mary Lyon Centre at MRC Harwell
2020

Stem Cell Institute
2020

Office of the Assistant Secretary for Planning and Evaluation
2020

IFOM
2017

European Institute of Oncology
2017

ETH Zurich
2017

Nicholas McGranahan Rachel Rosenthal Crispin T. Hiley Andrew J. Rowan Thomas B.K. Watkins and 95 more Gareth A. Wilson Nicolai J. Birkbak Selvaraju Veeriah Peter Van Loo Javier Herrero Charles Swanton Charles Swanton Mariam Jamal‐Hanjani Selvaraju Veeriah Seema Shafi Justyna Czyzewska-Khan Diana Johnson Joanne Laycock Leticia Bosshard‐Carter Rachel Rosenthal Pat Gorman Robert E. Hynds Gareth A. Wilson Nicolai J. Birkbak Thomas B.K. Watkins Nicholas McGranahan Stuart Horswell Richard Mitter Mickael Escudero Aengus Stewart Peter Van Loo Andrew Rowan Hang Xu Samra Turajlic Crispin T. Hiley Christopher Abbosh Jacki Goldman Richard Stone Tamara Denner Nik Matthews Greg Elgar Sophia Ward Marta Costa Sharmin Begum Ben Phillimore Tim Chambers Emma Nye Sofia Graca Maise Al Bakir Kroopa Joshi Andrew J.S. Furness Assma Ben Aïssa Yien Ning Sophia Wong Andy Georgiou Sergio A. Quezada John A. Hartley Helen L. Lowe Javier Herrero David Lawrence Sophia Ward Nikolaos Panagiotopoulos Shyam Kolvekar Mary Falzon Elaine Borg Teresa Marafioti Celia Simeon Gemma Hector Amy Smith Marie Aranda Marco Novelli Dahmane Oukrif Sam M. Janes Ricky M. Thakrar Martin Förster Tanya Ahmad SM Lee Dionysis Papadatos-Pastos Dawn Carnell R. Mendes Jeremy George Neal Navani Asia Ahmed Magali N. Taylor Junaid Choudhary Yvonne Summers Raffaele Califano P. W. J. Taylor Rajesh Shah Piotr Krysiak Kendadai Rammohan Eustace Fontaine Richard Booton Matthew Evison Philip Crosbie Stuart Moss Faiza Idries Leena Dennis Joseph Paul N. Bishop Anshuman Chaturved Anne Marie Quinn

Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. However, polymorphic nature locus has precluded accurate HLA copy-number analysis. Here, we heterozygosity in (LOHHLA), computational tool determine allele-specific copy number from sequencing data. Using LOHHLA, find that LOH occurs 40% non-small-cell lung cancers (NSCLCs) and associated with high subclonal neoantigen burden,...

10.1016/j.cell.2017.10.001 article EN cc-by Cell 2017-10-26

Clear-cell renal cell carcinoma (ccRCC) exhibits a broad range of metastatic phenotypes that have not been systematically studied to date. Here, we analyzed 575 primary and 335 biopsies across 100 patients with ccRCC, including two cases sampledat post-mortem. Metastatic competence was afforded by chromosome complexity, identify 9p loss as highly selected event driving metastasis ccRCC-related mortality (p = 0.0014). Distinct patterns dissemination were observed, rapid progression multiple...

10.1016/j.cell.2018.03.057 article EN cc-by Cell 2018-04-01

In mouse, a subset of dendritic cells (DCs) known as CD8α+ DCs has emerged an important player in the regulation T cell responses and promising target vaccination strategies. However, translation into clinical protocols been hampered by failure to identify humans. Here, we characterize population human that expresses DNGR-1 (CLEC9A) high levels BDCA3 resembles mouse phenotype function. We describe presence such spleens humans humanized mice report on protocol generate them vitro. Like DCs,...

10.1084/jem.20092618 article EN The Journal of Experimental Medicine 2010-05-17

The evolutionary features of clear-cell renal cell carcinoma (ccRCC) have not been systematically studied to date. We analyzed 1,206 primary tumor regions from 101 patients recruited into the multi-center prospective study, TRACERx Renal. observe up 30 driver events per and show that subclonal diversification is associated with known prognostic parameters. By resolving patterns event ordering, co-occurrence, mutual exclusivity at clone level, we deterministic nature clonal evolution. ccRCC...

10.1016/j.cell.2018.03.043 article EN cc-by Cell 2018-04-01

The Krebs cycle enzyme fumarate hydratase (FH) is a human tumor suppressor whose inactivation associated with the development of leiomyomata, renal cysts, and tumors. It has been proposed that activation hypoxia inducible factor (HIF) by fumarate-mediated inhibition HIF prolyl hydroxylases drives oncogenesis. Using mouse model, we provide genetic evidence Fh1-associated cyst formation Hif independent, as striking upregulation antioxidant signaling pathways revealed gene expression profiling....

10.1016/j.ccr.2011.09.006 article EN cc-by Cancer Cell 2011-10-01

The immunosuppressive protein PD-L1 is upregulated in many cancers and contributes to evasion of the host immune system. relative importance tumor microenvironment cancer cell-intrinsic signaling regulation expression remains unclear. We report that oncogenic RAS can upregulate cell through a mechanism involving increases mRNA stability via modulation AU-rich element-binding tristetraprolin (TTP). TTP negatively regulates elements 3′ UTR mRNA. MEK downstream leads phosphorylation inhibition...

10.1016/j.immuni.2017.11.016 article EN cc-by Immunity 2017-12-01
Frederick Arce Vargas Andrew J.S. Furness Isabelle Solomon Kroopa Joshi Leila Mekkaoui and 95 more Marta H. Lesko Enrique Miranda Rony Dahan Andrew Georgiou Anna Śledzińska Assma Ben Aïssa Dafne Franz Mariana Werner Sunderland Yien Ning Sophia Wong Jake Y. Henry Tim O’Brien David Nicol Ben Challacombe Stephen A. Beers Samra Turajlic Martin Gore James Larkin Charles Swanton Kerry Chester Martin Pulé Jeffrey V. Ravetch Teresa Marafioti Karl S. Peggs Sergio A. Quezada Lavinia Spain Andrew Wotherspoon Nick Francis Myles Smith D. Strauß Andrew J. Hayes Aspasia Soultati Mark Stares Lavinia Spain Joanna Lynch Nicos Fotiadis Archana Fernando Steve Hazell Ashish Chandra Lisa Pickering Sarah Rudman Simon Chowdhury Charles Swanton Mariam Jamal‐Hanjani Selvaraju Veeriah Seema Shafi Justyna Czyzewska-Khan Diana Johnson Joanne Laycock Leticia Bosshard‐Carter Gerald Goh Rachel Rosenthal Pat Gorman Nirupa Murugaesu Robert E. Hynds Gareth A. Wilson Nicolai J. Birkbak Thomas B.K. Watkins Nicholas McGranahan Stuart Horswell Richard Mitter Mickael Escudero Aengus Stewart Peter Van Loo Andrew Rowan Hang Xu Samra Turajlic Crispin T. Hiley Christopher Abbosh Jacki Goldman Richard Stone Tamara Denner Nik Matthews Greg Elgar Sophia Ward Jennifer Biggs Marta Costa Sharmin Begum Ben Phillimore Tim Chambers Emma Nye Sofia Graca Maise Al Bakir John A. Hartley Helen L. Lowe Javier Herrero David Lawrence Sophia Ward Nikolaos Panagiotopoulos Shyam Kolvekar Mary Falzon Elaine Borg Celia Simeon Gemma Hector Amy Smith Marie Aranda

CD25 is expressed at high levels on regulatory T (Treg) cells and was initially proposed as a target for cancer immunotherapy. However, anti-CD25 antibodies have displayed limited activity against established tumors. We demonstrated that expression largely restricted to tumor-infiltrating Treg in mice humans. While existing were observed deplete the periphery, upregulation of inhibitory Fc gamma receptor (FcγR) IIb tumor site prevented intra-tumoral cell depletion, which may underlie lack...

10.1016/j.immuni.2017.03.013 article EN cc-by Immunity 2017-04-01

The epithelium and immune compartment in the intestine are constantly exposed to a fluctuating external environment. Defective communication between these compartments at this barrier surface underlies susceptibility infections chronic inflammation. Environmental factors play significant, but mechanistically poorly understood, role intestinal homeostasis. We found that regeneration of epithelial cells (IECs) upon injury through infection or chemical insults was profoundly influenced by...

10.1016/j.immuni.2018.07.010 article EN cc-by Immunity 2018-08-01

Tumors comprise functionally diverse subpopulations of cells with distinct proliferative potential. Here, we show that dynamic epigenetic states defined by the linker histone H1.0 determine which within a tumor can sustain long-term cancer growth. Numerous types exhibit high inter- and intratumor heterogeneity H1.0, levels correlating differentiation status, patient survival, and, at single-cell level, stem cell markers. Silencing promotes maintenance self-renewing inducing derepression...

10.1126/science.aaf1644 article EN Science 2016-09-29
Maise Al Bakir Ariana Huebner Carlos Martínez‐Ruiz Kristiana Grigoriadis Thomas B.K. Watkins and 95 more Oriol Pich David A. Moore Selvaraju Veeriah Sophia Ward Joanne Laycock Diana Johnson Andrew Rowan Maryam Razaq Mita Akther Cristina Naceur‐Lombardelli Paulina Prymas Antonia Toncheva Sonya Hessey Michelle Dietzen Emma Colliver Alexander M. Frankell Abigail Bunkum Emilia L. Lim Takahiro Karasaki Christopher Abbosh Crispin T. Hiley Mark S. Hill Daniel E. Cook Gareth A. Wilson Roberto Salgado Emma Nye Richard Stone Dean A. Fennell Gillian Price Keith M. Kerr Babu Naidu Gary Middleton Yvonne Summers Colin R. Lindsay Fiona Blackhall Judith Cave Kevin G. Blyth Arjun Nair Asia Ahmed Magali N. Taylor Alexander James Procter Mary Falzon David Lawrence Neal Navani Ricky M. Thakrar Sam M. Janes Dionysis Papadatos-Pastos Martin Förster SM Lee Tanya Ahmad Sergio A. Quezada Karl S. Peggs Peter Van Loo Caroline Dive Allan Hackshaw Nicolai J. Birkbak Simone Zaccaria J.F. Lester Amrita Bajaj Apostolos Nakas Azmina Sodha-Ramdeen Keng Ang Mohamad Tufail Mohammed Fiyaz Chowdhry Molly Scotland Rebecca Boyles Sridhar Rathinam Claire Wilson Domenic Marrone Sean Dulloo Gurdeep Matharu Jacqui Shaw Joan Riley Lindsay Primrose Ekaterini Boleti Heather Cheyne Mohammed S. Khalil Shirley Richardson Tracey Cruickshank Sarah Benafif Kayleigh Gilbert Akshay J. Patel Aya Osman Christer Lacson Gerald Langman Helen Shackleford Madava Djearaman Salma Kadiri Angela Leek Jack Davies Hodgkinson Nicola Totten Ángeles Montero Elaine Smith Eustace Fontaine Felice Granato

Metastatic disease is responsible for the majority of cancer-related deaths

10.1038/s41586-023-05729-x article EN cc-by Nature 2023-04-12

A role for vitamin D in immune modulation and cancer has been suggested. In this work, we report that mice with increased availability of display greater immune-dependent resistance to transplantable cancers augmented responses checkpoint blockade immunotherapies. Similarly, humans, D-induced genes correlate improved inhibitor treatment as well immunity overall survival. mice, is attributable the activity on intestinal epithelial cells, which alters microbiome composition favor

10.1126/science.adh7954 article EN Science 2024-04-25

Abstract Increasing rates of autoimmune and inflammatory disease present a burgeoning threat to human health 1 . This is compounded by the limited efficacy available treatments high failure during drug development 2 , highlighting an urgent need better understand mechanisms. Here we show how functional genomics could address this challenge. By investigating intergenic haplotype on chr21q22—which has been independently linked bowel disease, ankylosing spondylitis, primary sclerosing...

10.1038/s41586-024-07501-1 article EN cc-by Nature 2024-06-05

Abstract Understanding the role of tumor microenvironment (TME) in lung cancer is critical to improving patient outcomes. We identified four histology-independent archetype TMEs treatment-naïve early-stage using imaging mass cytometry TRACERx study (n = 81 patients/198 samples/2.3 million cells). In immune-hot adenocarcinomas, spatial niches T cells and macrophages increased with clonal neoantigen burden, whereas such an increase was observed for plasma B immune-excluded squamous cell...

10.1158/2159-8290.cd-23-1380 article EN cc-by Cancer Discovery 2024-04-06

Mucin-type O-glycans (O-glycans) are highly expressed in vascular ECs. However, it is not known whether they important for development. To investigate the roles of EC O-glycans, we generated mice lacking T-synthase, a glycosyltransferase encoded by gene C1galt1 that critical biosynthesis core 1-derived ECs and hematopoietic cells (termed here EHC T-syn(-/-) mice). exhibited embryonic neonatal lethality associated with disorganized blood-filled lymphatic vessels. Bone marrow transplantation...

10.1172/jci36077 article EN Journal of Clinical Investigation 2008-10-16

Abstract Murine mesenchymal stem cells are capable of differentiation into multiple cell types both in vitro and vivo may be good candidates to use as therapy for diseased or damaged organs. We have previously reported a method enriching population murine MSCs that demonstrated diverse potential vivo. In this study, we show enriched embolize within lung capillaries following systemic injection then rapidly expand within, invade into, the parenchyma, forming tumor nodules. These lesions...

10.1634/stemcells.2006-0762 article EN Stem Cells 2007-03-15

Highlights•Inducible disruption of PI3-kinase p110α interaction with RAS was modeled in mice•Blocking RAS/p110α established lung tumors causes partial regression•Blocking binding has effects similar to deletion on tumor regression•Coordinate MEK inhibition is required for major regression Kras mutant cancerSummaryRAS proteins directly activate PI3-kinases. Mice bearing a germline mutation the domain subunit PI3-kinse are resistant development RAS-driven tumors. However, it unknown whether...

10.1016/j.ccr.2013.09.012 article EN cc-by-nc-nd Cancer Cell 2013-11-01
Coming Soon ...